Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Metabolism of [14C]-BI 44370 BS in Healthy Males
NCT02215772Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of BI 44370 in migraine, sponsored by Boehringer Ingelheim. Primary endpoints: Individual time course profiles of [14C]-radioactivity in whole blood, plasma, urine, Individual time course profiles of [14C]-radioactivity in faeces and 13 more. Started Sep 2008; status: completed.
02
Drugs
BI 44370
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02215772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215772.